Suckling and adult mice were infected intragastrically with different doses of viable Listeria monocytogenes. The 50% lethal dose for the intragastric infection was i0.7 CFU for suckling mice, while adult mice were highly resistant and the 500 lethal dose was more than 109.3 CFU. When adult mice were infected intragastrically with 5 x 108 CFU of L. monocytogenes, no mice died. However, 35% of adult mice died when they were treated with cyclosporin A 1 day before infection. Although mice did not die when treated with an L. monocytogenes-resistant broad-spectrum cephalosporin, sodium cefbuperazone, before and during infection, the number of L. monocytogenes bacteria increased in the feces. The sodium cefbuperazone treatment of mice resulted in superinfection, i.e., a marked decrease ofEscherichia coli and an increase ofEnterococcus spp. in the intestines.
Listeria monocytogenes is a gram-positive, facultative intracellular bacterium that is ordinarily nonpathogenic to healthy persons; however, it is important as an opportunistic pathogen. The individuals at highest risk are pregnant women and their fetuses, newborn infants, debilitated elderly persons, and immunocompromised hosts. Recent epidemiologic investigations provided evidence that L. monocytogenes may be transmitted as an enteric pathogen by contaminated foods, e.g., vegetables, milk, and dairy products (6, 10, 26) , suggesting that natural L. monocytogenes infection occurs by the oral route.
Host resistance against L. monocytogenes infection is affected by T-cell-dependent mechanisms (14) and the administration of cyclosporin A (CsA), which inhibits many T-celldependent functions (22) and decreases antilisterial resistance in mice (7, 17, 25, 28) . On the other hand, it has been reported that the intestinal bacterial flora is important in the interference of the colonization of L. monocytogenes in the intestinal tracts (4, 31) , suggesting that the fate of infection by the oral route depends on the intestinal bacterial flora. Therefore, we focused our studies on the effect of CsA and an L. monocytogenes-resistant broad-spectrum cephalosporin, sodium cefbuperazone (CBPZ), on the susceptibilities of specific-pathogenfree mice to an intragastric infection with L. monocytogenes. In this report, we provide evidence that a combination of immunosuppression and interference of intestinal bacterial flora results in the marked augmentation of susceptibility of mice to an intragastric infection with L. monocytogenes.
MATERIALS AND METHODS
Mice. Specific-pathogen-free female ddY mice (obtained from SLC, Hamamatsu, Shizuoka, Japan), 5 weeks old and weighing 24 to 26 g, were used. In some experiments, 16-to 18-day-old suckling mice (weighing 7 to 11 g) were used. The suckling mice were kept with their mothers and handled as little as possible (3) .
Bacteria. L. monocytogenes lb 1684 cells (16) were maintained in tryptic soy broth (Difco Laboratories, Detroit, Mich.) at -70°C. In each experiment, an aliquot was thawed, inoculated into 200 ml of tryptic soy broth, and incubated at 37°C for 15 to 16 h. The organisms were collected by centrifugation and resuspended in pyrogen-free saline. The concentration of the cell suspension was adjusted spectrophotometrically at 550 nm. Mice were infected intragastrically with 0.2 ml of a solution containing 5 x 108 CFU of viable L. monocytogenes in 0.01 M phosphate-buffered saline (PBS; pH 7.4). For intragastric feeding, we slipped an animal-feeding needle (0.9 by 70 mm; Natsume Factory, Inc., Tokyo, Japan) past the pharynx into the stomach, where the inoculum was injected. The mice were not anesthetized for this procedure.
Treatment with CsA. CsA was donated by Sandoz AG (Basel, Switzerland). It was dissolved in pharmaceutical-grade olive oil with sonication before use. One hundred milligrams of the drug (in 0.2-ml quantities) per kg of body weight was injected intraperitoneally 1 day before infection with L. monocytogenes (17) . Control mice were injected with drug-free olive oil.
Treatment with an antibacterial agent. CBPZ was obtained from Toyama Chemical Co., Tokyo, Japan. The MIC of CBPZ for L. monocytogenes lb 1684 was more than 60 ,ug/ml. The MIC was determined by a broth microdilution method (23) by using brain heart infusion broth (Difco). Bacteria were inoculated at a final concentration of 106 CFU/ml. For until day 10 of infection ( Fig. 2) . Similar patterns were observed in the numbers of bacterial cells between the spleens and mesenteric lymph nodes and between Peyer's patches and feces. No increase in the number of L. monocytogenes bacteria in the Peyer's patches and feces was seen, and the number fell to undetectable levels before day 5 of infection. In contrast, the number of bacteria in the mesenteric lymph nodes increased from day 1 to day 3 of infection and then decreased. L. monocytogenes appeared in the spleens on day 2 of infection. Thereafter, the kinetics of the number of bacterial cells was similar to that of the mesenteric lymph nodes.
Elect of CsA and CBPZ on susceptibilities to intragastric infection in adult mice. Adult mice were infected intragastrically with 5 x 108 CFU of L. monocytogenes, and they were divided into the following four groups. Mice of the first group were injected intraperitoneally with 100 mg of CsA per kg 1 day before infection. Under these conditions, almost all of the CsA-treated mice died by intravenous infection with a 0.1 50% lethal dose of L. monocytogenes (17) . Mice of the second group were injected intraperitoneally with a 500-mg/kg dose of CBPZ, which showed no antibacterial activity against the strain of L. monocytogenes used herein, daily from day -2 to day 9 of infection. The treatment disturbed the normal bacterial flora of the intestines of the mice: the number of E. coli in the feces decreased to less than 100 CFU/g; however, the number of Enterococcus spp. increased to almost 100-fold in the feces of the CBPZ-treated mice (data not shown). Mice of the third group were treated with both CsA and CBPZ. Mice of the fourth group were treated with drug-free olive oil and PBS. These mice were used as a control. The survival rate for each group is shown in Fig. 3 . All control mice and almost all CBPZ-treated mice did not die, whereas a significant decrease in the survival rate was observed in CsA-treated mice (P < 0.01). Furthermore, the mortality was accelerated by treatment with a combination of CsA and CBPZ, and most of the mice in this group died from day 2 to day 5 of infection. Effect of CBPZ and CsA on susceptibilities to an intragastric infection with L. monocytogenes in adult mice. Mice were infected with 5 x 108 CFU of bacteria. They were injected intraperitoneally with CBPZ from day -2 to day 9 (v), with CsA on day -1 of infection (LI), or with both (E). The control group was treated with drug-free olive oil and PBS (0). Each result represents a group of 10 mice from two experiments. An asterisk indicates a significant difference from the value for the control group at a P of <0.01. 6A), mesenteric lymph nodes (Fig. 6B) , and feces (Fig. 6C ) depended on the infectious doses. The bacterial growth in the spleens and mesenteric lymph nodes was observed in both the CsA-and CBPZ-treated mice, which were infected with only the four groups were compared on day 1 (Fig. 4) and day 3 ( Fig. 5 ) of infection. In the spleens, only the lower concentration of bacteria was found in the control mice on day 1, whereas significantly augmented growth of bacteria was observed in the other three groups (P < 0.01) (Fig. 4A ). On day 3 (Fig. 5A) , the number of bacteria in mice which received CsA only or both CsA and CBPZ was still significantly more than that in the control mice (P < 0.01 and P < 0.05, respectively). Similar results were obtained for the mesenteric lymph nodes (Fig. 4B and SB) , although the bacterial growth in CBPZtreated mice was comparable to that in the control mice. In the Peyer's patches (Fig. 4C and 5C ), mice which received the combined treatment showed a significant increase in the bacterial numbers on either day 1 or day 3 (P < 0.01). In the feces (Fig. 4D and SD) , the number of bacteria in both CsAand CBPZ-treated mice was significantly more than that in the control mice (P < 0.01).
Effect of CsA and CBPZ on host resistance to intragastric infection with different doses of L. monocytogenes. Both CsAand CBPZ-treated mice and the control mice were infected intragastrically with different doses of viable L. monocytogenes, and the numbers of bacterial cells in the spleens, mesenteric lymph nodes, and feces were estimated on day 3 of infection. The numbers of L. monocytogenes bacteria in the spleens ( Mice, which were infected with different doses of bacteria, were injected with CBPZ from day -2 to day 2 and with CsA on day -1 of infection (hatched bars). The control group was treated with drug-free olive oil and PBS (open bars). The numbers of bacteria in the spleens (A), mesenteric lymph nodes (B), and feces (C) were determined on day 3 of infection. Each result is for a group of five mice. Single and double asterisks indicate significant differences from the value for the control group at P values of <0.01 and <0.05, respectively. 500 CFU of the bacterium, although this observation was not made for the control mice. The bacterial cells were detected in the feces when both CsA-and CBPZ-treated mice were infected with more than 5 x 106 CFU of the bacteria. In the experiments, the survival of the remaining mice was observed until day 10 of infection. The mortalities of mice which had received 5 x 108, 5 x 106, 5 x 104, or 5 x 102 CFU were 70, 20, 10, and 10%, respectively.
DISCUSSION
The studies presented here demonstrated that both cellular immunity and intestinal bacterial flora are required for host resistance against an intragastric infection with L. monocytogenes.
Adult mice except those that are germfree reportedly show high resistance against intragastric L. monocytogenes infection (13, 21, 31) , although Pine et al. (20) reported that intragastric and intraperitoneal 50% lethal doses of L. monocytogenes were comparable. In the present study, adult mice were highly resistant to the intragastric infection compared with the systemic infection; i.e., the 50% lethal dose of an intragastric infection with the L. monocytogenes strain used herein was more than 1093 CFU (Fig. 1) , while that of an intravenous infection with the strain was 1053 CFU (18) . In contrast, suckling mice were highly susceptible to intragastric infection. It has been reported that suckling mice are markedly susceptible to systemic infection with L. monocytogenes (11, 19) and that intracellular killing activity against L. monocytogenes, antigen-presenting abilities of macrophages, and generation of L. monocytogenes-specific memory T cells are reduced in suckling mice (3, 11, 12, 19) . Furthermore, it is known that the intestinal bacterial flora differs markedly between suckling and adult mice (24) . From the results, therefore, we noticed the effects of both immunological and bacterial changes on susceptibilities to an intragastric infection with L. monocytogenes.
The administration of CsA to humans and animals results in the inhibition of many T-cell-dependent functions (22) . An important effect of CsA is its ability to inhibit production of cytokines, including gamma interferon, interleukin-1, and interleukin-2. Host resistance against systemic infection with L. monocytogenes is inhibited in CsA-treated mice (7, 25, 28) . We demonstrated previously that a decreased production of endogenous gamma interferon, which is crucial in antilisterial resistance (2) , is involved in the CsA effect (17) . In the present study, antilisterial resistance against the intragastric infection decreased in the spleens and mesenteric lymph nodes of CsA-treated adult mice and some of the mice finally died (Fig.  3) , whereas CsA did not affect the growth of L. monocytogenes cells in the intestines, i.e., the primary site of the oral infection (Fig. 4 and 5 ).
Zachar and Savage (31) reported that an intragastric inoculation of only 100 CFU of L. monocytogenes cells resulted in colonization in the gastrointestinal tracts of germfree mice, whereas colonization of the bacterium was not observed in those of specific-pathogen-free mice which were inoculated with as much as 5 x 107 CFU of the bacterium. Czuprynski and Balish (4) also observed that L. monocytogenes colonized the gastrointestinal tracts of germfree rats but not those of conventional animals. Furthermore, they demonstrated that L. monocytogenes colonies were cleared from the gastrointestinal tracts of germfree rats after conventionalization. These results suggested that the intestinal bacterial flora is important in the interference of the colonization of L. monocytogenes in the gastrointestinal tracts. We investigated the effect of an L. monocytogenes-resistant broad-spectrum cephalosporin, CBPZ, on the fate of the intragastric infection. CBPZ treatment of adult mice resulted in superinfection, i.e., a marked decrease of E. coli, which is sensitive to CBPZ, and an increase of Enterococcus spp., which are resistant to the drug, were observed. The growth of L. monocytogenes was enhanced in CBPZ-treated mice (Fig. 5) , whereas the bacterial growth in the spleens and mesenteric lymph nodes or the survival rates were not affected (Fig. 3 to 5 ). In contrast, treatment with a combination of CsA and CBPZ resulted in enhancement of the growth of L. monocytogenes in all of the organs examined (Fig.  4 and 5) . Furthermore, acceleration of death from listeriosis was observed in these animals (Fig. 3) . The results suggest that both cellular immunity and the intestinal bacterial flora might be essential in the host resistance against oral L. monocytogenes infection. When L. monocytogenes is given orally, the bacteria penetrate into Peyer's patches, disseminate via the efferent lymphocytes to the mesenteric lymph nodes, and finally form the infectious foci in the spleens and livers (31) . In the present study, we showed that CBPZ might disturb the intestinal bacterial flora, leading easily to L. monocytogenes colonization of the intestinal tracts. On the other hand, CsA might suppress the functions of T cells in the Peyer's patches, mesenteric lymph nodes, spleens, and livers to disseminate L. monocytogenes and lead it to grow explosively.
Although broad-spectrum cephalosporins are now used in therapies of various bacterial infections, L. monocytogenes is consistently resistant to these antibiotics (5, 15, 29) . Furthermore, it has been reported that L. monocytogenes can be carried easily in the gastrointestinal tracts of humans (1, 8, 9, 27) . Our present results suggest that the administration of such drugs might trigger systemic L. monocytogenes infection via oral infection in immunocompromised hosts. Furthermore, CsA-and CBPZ-treated mice might be a useful model for analyzing mechanisms of oral L. monocytogenes infection and to prevent the infection.
